Cystagon Capsule
Product Images NDC 0378-9040

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Cystagon (NDC 0378-9040). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cysteamine Bitartrate Structural Formula (3aab3b39 52b6 4a79 9a5c 7baa7574f24f 01)

Cysteamine Bitartrate Structural Formula (3aab3b39 52b6 4a79 9a5c 7baa7574f24f 01)
Chemical structure diagram showing the molecular formula of cysteamine bitartrate, the active ingredient in Cystagon. The diagram depicts its specific arrangement of atoms and bonds.*
FDA Label Image

The Mean White Cell Cystine Concentration And Mean Cysteamine Plasma Concentration-time Profile (3aab3b39 52b6 4a79 9a5c 7baa7574f24f 02)

The Mean White Cell Cystine Concentration And Mean Cysteamine Plasma Concentration-time Profile (3aab3b39 52b6 4a79 9a5c 7baa7574f24f 02)
A line graph depicting cystamine concentration (mg/L) and WBC cystine content (nmol/mg protein) over time (hours). The graph shows two data series: WBC cystine decreasing and cystamine concentration increasing and then leveling off during the 6-hour period.*
FDA Label Image

Image 01

Image 01
Cystagon 50 mg capsules label featuring cysteamine bitartrate as the active ingredient. The label includes the NDC 0378-9040-05, shows the Mylan Pharmaceuticals Inc. logo and name, and states the product is for prescription use only with a 500-capsule count. Storage instructions and dispensing cautions are provided, along with a barcode and space for variable data coding.*
FDA Label Image

Image 02

Image 02
Label for Cystagon (cysteamine bitartrate) Capsules 150 mg by Mylan Pharmaceuticals Inc. The label shows the dosage strength, capsule count of 500, NDC 0378-9045-05, and storage instructions. It includes a barcode and states the product is for oral use with child-resistant packaging.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.